Xeris Biopharma Holdings, Inc. (XERS) › Weighted Average Diluted SharesXeris Biopharma Holdings, Inc. (XERS) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2021-12-31: 79.03M2022-12-31: 135.63M2023-12-31: 137.67M2024-12-31: 146.77M2025-12-31: 172.74M172.74M2021-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-31172.74M+17.7%2026-03-02From 2025-01-012024-12-31146.77M+6.6%2026-03-02From 2024-01-012023-12-31137.67M+1.5%2026-03-02From 2023-01-012022-12-31135.63M+71.6%2025-03-06From 2022-01-012021-12-3179.03M—2024-03-06From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)